Dipropyltryptamine

Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Dipropyltryptamine
Clinical data
Routes of
administration
Ingestion, inhalation, intravenous or intramuscular injection
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC16H24N2
Molar mass244.38 g/mol
3D model (JSmol)
Melting point174.5 to 178 °C (Expression error: Unrecognized word "to". °F)

WikiDoc Resources for Dipropyltryptamine

Articles

Most recent articles on Dipropyltryptamine

Most cited articles on Dipropyltryptamine

Review articles on Dipropyltryptamine

Articles on Dipropyltryptamine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Dipropyltryptamine

Images of Dipropyltryptamine

Photos of Dipropyltryptamine

Podcasts & MP3s on Dipropyltryptamine

Videos on Dipropyltryptamine

Evidence Based Medicine

Cochrane Collaboration on Dipropyltryptamine

Bandolier on Dipropyltryptamine

TRIP on Dipropyltryptamine

Clinical Trials

Ongoing Trials on Dipropyltryptamine at Clinical Trials.gov

Trial results on Dipropyltryptamine

Clinical Trials on Dipropyltryptamine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Dipropyltryptamine

NICE Guidance on Dipropyltryptamine

NHS PRODIGY Guidance

FDA on Dipropyltryptamine

CDC on Dipropyltryptamine

Books

Books on Dipropyltryptamine

News

Dipropyltryptamine in the news

Be alerted to news on Dipropyltryptamine

News trends on Dipropyltryptamine

Commentary

Blogs on Dipropyltryptamine

Definitions

Definitions of Dipropyltryptamine

Patient Resources / Community

Patient resources on Dipropyltryptamine

Discussion groups on Dipropyltryptamine

Patient Handouts on Dipropyltryptamine

Directions to Hospitals Treating Dipropyltryptamine

Risk calculators and risk factors for Dipropyltryptamine

Healthcare Provider Resources

Symptoms of Dipropyltryptamine

Causes & Risk Factors for Dipropyltryptamine

Diagnostic studies for Dipropyltryptamine

Treatment of Dipropyltryptamine

Continuing Medical Education (CME)

CME Programs on Dipropyltryptamine

International

Dipropyltryptamine en Espanol

Dipropyltryptamine en Francais

Business

Dipropyltryptamine in the Marketplace

Patents on Dipropyltryptamine

Experimental / Informatics

List of terms related to Dipropyltryptamine


Dipropyltryptamine (DPT) is a psychedelic drug belonging to the tryptamine family. It is found either as its crystalline hydrochloride salt or as an oily or crystalline base. It has not been found to occur naturally.

Frequent physical effects are nausea, numbness of the tongue or throat, and pupil dilation.

Hallucinogenic Properties

While dipropyltryptamine is chemically similar to dimethyltryptamine, the effects are markedly different.

The most prominent features of the DPT experience are increased significance or intensity of music, colors take on a new intensity or appearance, the body may have a buzz or vibratory feeling, a pleasant sensation of warmth, complete ego loss, apparitions of faces, and visions of bizarre creatures and alien lands.

While seeing other beings under the influence of DPT is not uncommon, the perspective is more as an observer or watcher, as contrasted to the more personal real-feeling entity contact reported with DMT.

Also reported is a loss of ego boundary; for example, the boundary between the self and a table may not be easy to distinguish. Difficulty distinguishing other boundaries is common as well. For example, different colors may be difficult to distinguish. Other sensory input may also become blended. This is distinct from synaesthesia.

A user may also encounter the feeling of experiencing the life of someone else, or having had all possible experiences simultaneously. One may have the experience of seeing the universe from different locations in space and time.

Visuals are often geometric, wavy, and/or spiraled. Other visual distortions and hallucinations tend to be experienced in the peripheral vision. The self or the environment may take on a stylized cartoon-like look or feel. Pleasant flashes of light and sparkles are also common.

Dose

Smoked: When smoked, the effects of DPT have an onset in minutes and a duration of less than one hour. Dosage ranges from 30-100 mg.

Insufflation: Average onset for insufflation of DPT is five to fifteen minutes, and typical dosage ranges from 45-225 mg, but the most popular dose is around 100 mg.

Intramuscular: When injected into the muscle, onset ranges from one minute to fifteen minutes. Typical dosage ranges from 20-110 mg.

Intravenous: When injected intravenously, onset ranges from five to fifteen seconds. Typical dosage ranges from 10-75 mg.

Oral Ingestion: DPT is metabolized by the enzyme monoamine oxidase. While DPT is orally active on its own, the combination with a monoamine oxidase inhibitor (MAOI) can increase the length and intensity of the experience. Oral dosages of 150 - 250 mg are commonly reported, with an onset of 20-60 minutes (depending on stomach content).[1]

Religious use

DPT is used as a religious sacrament by the Temple of the True Inner Light, a New York City offshoot of the Native American Church. The Temple believes DPT and other entheogens are physical manifestations of God.[2]

References

Notes

Entry in the book TIHKAL about DPT - http://www.erowid.org/library/books_online/tihkal/tihkal09.shtml

External links

Template:TiHKAL Template:Hallucinogenic tryptamines Template:Tryptamines sv:Dipropyltryptamin

Template:WH Template:WS